Page 157 - CW E-Magazine (6-5-2025)

Pharmaceuticals Hydrocarbons

STRONG PERFORMANCE CALL FOR COOPERATION

Laurus Labs’s posts three-fold increase in Q4 net profi t India, Saudi Arabia to work together to enhance

Hyderabad-based Laurus Labs said year, it added. Revenue increased to platforms and commercial excellence, stability of global oil markets
its consolidated profi t increased three- Rs. 5,554-crore in last fi scal year as thanks to team commitment to the uni-
fold to Rs. 234-crore for the Jan-March compared with Rs. 5,041-crore in the fi ed vision of delivering high quality India has agreed to work with Saudi oil and its derivatives,” the joint state- buildings, industry, and transportation
2025 quarter, driven by strong sales. 2023-24 fi nancial year. integrated solution and securing our Arabia to enhance the stability of global ment said. sectors, and raising awareness of its
The company had reported a net profi t long-term growth potential,” he added. oil markets and to balance global importance,” the statement said. On cli-
of Rs. 76-crore for the same quarter of “We delivered very good Q4 results energy market dynamics, according to a The two sides emphasised the im- mate change, both sides reaffi rmed the
FY24. and continued our transformative pro- Going ahead, the company remains joint statement issued after conclusion portance of cooperation in the fi eld of importance of adhering to the principles
gress, refl ecting robust demand for our confi dent in its growth expectations as of Prime Minister Narendra Modi’s green and clean hydrogen, including of the United Nations Framework Con-
Revenue increased to Rs. CDMO off erings and meeting complex it looks forward to executing on long- visit to Saudi Arabia. stimulating demand, developing hydro- vention on Climate Change and the Paris
1,720-crore for the fourth quarter as customer needs,” Laurus Labs’s lead programmes and new assets ramp- gen transport and storage technologies, Agreement and the need to develop and
compared with Rs. 1,440-crore in the founder & CEO Mr. Satyanarayana ing up with revenue increasing over “The Indian side agreed to work exchanging expertise and experiences implement climate agreements with a
year-ago period, Laurus Labs said in a Chava said. FY25 with continued focus on opera- with the kingdom to enhance the sta- to implement best practices. focus on emissions rather than sources.
regulatory fi ling. tional excellence, the company’s CFO bility of global oil markets and to
“Our business remains well posi- Mr. V. V. Ravi Kumar said. “Our capital balance global energy market dynamics. “The two sides also acknowledged The two sides stressed the impor-
For FY25, the company said its tioned to evolve into a well-diversifi ed allocation strategy remains unchanged, They emphasised the need to ensure the need to work on developing supply tance of cooperation to develop appli-
profi t rose to Rs. 358-crore as against CMO/CDMO company with promising prioritising investments into high-value security of supply for all energy sources chains and projects linked to the energy cations of the circular carbon economy
Rs. 161-crore in the 2023-24 fi scal pipeline, enabling several technology business opportunities,” he added. in global markets. They agreed on sector, enabling cooperation between by promoting policies that use the
the importance of enhancing coope- companies, enhancing cooperation in circular carbon economy as a tool to
Lupin gets USFDA nod for generic kidney disease ration in several areas in the energy the fi eld of energy effi ciency and ratio- manage emissions and achieve climate

sector, including the supply of crude nalizing energy consumption in the change objectives.
treatment drug
Lupin said it has received approval 30-mg, 45-mg, 60-mg, and 90-mg, Nagpur facility and will be launched Reliance imported more Russian oil in March
from the US health regulator for its Lupin said in a regulatory fi ling. These soon,” the company said. Commenting
generic version of Tolvaptan tablets are bioequivalent to Jynarque tablets in on the approval, Lupin’s CEO Ms.Vinita as against February
indicated for a certain type of kidney the same strengths of Otsuka Pharma- Gupta said, “This marks a signifi cant
disease. ceutical Company Ltd., it added. entry into the nephrology segment and Reliance Industries Ltd. imported India imported 5.3-million barrels India imported an average 4.88-million
demonstrates our commitment to ad- about 532,700 barrels per day (bpd) of per day (bpd) oil in March, a growth bpd oil, up 5% from a year ago. Russia
The approval by the US Food and “Lupin is the exclusive fi rst-to-fi le dressing the unmet needs of patients Russian oil in March, up 17.3% from of 1.3% from the previous month and continued to be the top oil supplier to
Drug Administration (USFDA) is for for this product and is eligible for 180 globally.” These tablets had an estimated February, according to ship tracking 3.8% from a year earlier, the Reuters India in 2024-25 followed by Iraq and
the abbreviated new drug application days of generic drug exclusivity. This annual sale of nearly $1.5-bn in the US data obtained by Reuters’ industry report revealed. In 2024-25 fi scal year, Saudi Arabia, the data showed.
for Tolvaptan tablets of strengths 15-mg, product will be manufactured at Lupin’s in 2024. sources. Russian oil accounted for
about 48.5% of Reliance overall crude ‘India’s crude oil imports from
Sai Life Sciences, DHL Express ink sustainable imports in March, the data showed.
The Reuters report did not identify the Russia likely to hit two-year high
shipping solution pact sources.
in April’
Global logistics provider, DHL ers, through its ‘GoGreen Plus’ pro- carbon emissions of their critical shipments Reliance’s overall monthly imports
Express, has partnered with Hyderabad- duct off ering. Mr. R. S. Subramanian, to global destinations”. Sai Life Sciences declined about 19% to 1.1-million bpd, India’s crude oil imports from its sumer’s seaborne crude oil trade with
based pharma fi rm, Sai Life Sciences, to Senior Vice President – South Asia, works with over 300 global innovator the Reuters data showed, ahead of largest supplier Russia are expected Russia, which had been subdued due
use DHL’s ‘GoGreen Plus (GGP)’ service, DHL Express, said, “The life sciences pharma and biotech companies to accele- maintenance shutdown of units at one to surpass 2-million barrels per day to the US sanctions. According Kpler,
a shipping solution that uses sustainable and healthcare sector is a focus area for rate the pace of their drug discovery, of its refi neries. (mbpd) in April – the highest since May April 2025 volumes are shaping up to be
aviation fuel (SAF). growth outlined in our ‘Strategy 2030’. development and commercialisation. 2023, a Hindu BusinessLine report said “particularly strong”. Mr. Sumit Ritolia,
Russia’s state oil fi rm Rosneft has quoting data from global real-time data Kpler’s Lead Research Analyst for Re-
The collaboration is part of DHL’s GoGreen Plus is very relevant to key The latest move could help Sai Life a deal to supply nearly 500,000-bpd and analytics provider, Kpler. fi ning & Modeling, said, “As of April 22,
Strategy 2030, wherein it has set itself players here who have a committed road Sciences achieve a greenhouse gas of crude to Reliance in the biggest India’s crude oil imports from Russia for
the goal of being the ‘Green Logis- map on carbon footprint reduction. It emissions reduction of up to 90 percent ever energy deal between the two The development also refl ects on the April 2025 are estimated at 2.1 mbpd –
tics of Choice’ for all its stakehold- will help our customers address Scope 3 for its international logistics needs. countries. uptick in the world’s third largest con- potentially the highest since May 2023.”

156 Chemical Weekly May 6, 2025 Chemical Weekly May 6, 2025 157

Contents Index to Advertisers Index to Products Advertised